Topics

Repurposed quinacrine can reduce tumor burden in mice bearing HNSCC xenograft tumors

13:59 EDT 11 Oct 2019 | News-Medical.net

The authors have developed the Accelera TED platform to repurpose drugs for HNSCC treatment; using in vitro assays and in vivo models.

Original Article: Repurposed quinacrine can reduce tumor burden in mice bearing HNSCC xenograft tumors

NEXT ARTICLE

More From BioPortfolio on "Repurposed quinacrine can reduce tumor burden in mice bearing HNSCC xenograft tumors"

Quick Search

Relevant Topic

Immunoassay - ELISA
Immunoassays are quick and accurate tests to detect specific molecules. Immunoassays rely on an antibody to bind to the specific structure of a molecule. Antibodies are proteins generated by animals in response to the invasion of a foreign molecule (anti...